These diets deliver a greater improvement in fat oxidation and insulin sensitivity that might explain the significant decrease in the hepatic steatosis and central adiposity which are crucial aspects for MASLD/T2DM management [63]. This evidence concerns the gene INS and Hepatic steatosis.